NCT02387710View on ClinicalTrials.gov

Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

July 31, 2016

Conditions
Sleep Apnea, Obstructive
Interventions
DRUG

Tiagabine

GABA reuptake inhibitor

DRUG

Placebo

Placebo comparator

Trial Locations (1)

02115

Sleep Disorders Research Program Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT02387710 - Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea | Biotech Hunter | Biotech Hunter